CL2013000483A1 - Agente de formación de imagen que comprende un péptido cíclico de enlace c-met radioetiquetado por 18f; composicion de agente de formación de imagen; precursor util en la formación del péptido cíclico; método para la preparacion del peptido cíclico. - Google Patents

Agente de formación de imagen que comprende un péptido cíclico de enlace c-met radioetiquetado por 18f; composicion de agente de formación de imagen; precursor util en la formación del péptido cíclico; método para la preparacion del peptido cíclico.

Info

Publication number
CL2013000483A1
CL2013000483A1 CL2013000483A CL2013000483A CL2013000483A1 CL 2013000483 A1 CL2013000483 A1 CL 2013000483A1 CL 2013000483 A CL2013000483 A CL 2013000483A CL 2013000483 A CL2013000483 A CL 2013000483A CL 2013000483 A1 CL2013000483 A1 CL 2013000483A1
Authority
CL
Chile
Prior art keywords
cyclic peptide
radiolabelled
met
preparation
image forming
Prior art date
Application number
CL2013000483A
Other languages
English (en)
Spanish (es)
Inventor
Peter Brian Iveson
Rajiv Bhalla
Bard Indrevoll
Gareth Getvoldsen
Original Assignee
Ge Healthcare Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ge Healthcare Ltd filed Critical Ge Healthcare Ltd
Publication of CL2013000483A1 publication Critical patent/CL2013000483A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/088—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins conjugates with carriers being peptides, polyamino acids or proteins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/64—Cyclic peptides containing only normal peptide links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1833—Hepatocyte growth factor; Scatter factor; Tumor cytotoxic factor II

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nuclear Medicine (AREA)
CL2013000483A 2010-08-18 2013-02-18 Agente de formación de imagen que comprende un péptido cíclico de enlace c-met radioetiquetado por 18f; composicion de agente de formación de imagen; precursor util en la formación del péptido cíclico; método para la preparacion del peptido cíclico. CL2013000483A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1013808.9A GB201013808D0 (en) 2010-08-18 2010-08-18 Peptide radiotracer compositions

Publications (1)

Publication Number Publication Date
CL2013000483A1 true CL2013000483A1 (es) 2014-03-07

Family

ID=42938098

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2013000483A CL2013000483A1 (es) 2010-08-18 2013-02-18 Agente de formación de imagen que comprende un péptido cíclico de enlace c-met radioetiquetado por 18f; composicion de agente de formación de imagen; precursor util en la formación del péptido cíclico; método para la preparacion del peptido cíclico.

Country Status (19)

Country Link
US (1) US9533059B2 (enExample)
EP (1) EP2605802B1 (enExample)
JP (1) JP6014592B2 (enExample)
KR (1) KR101853993B1 (enExample)
CN (1) CN103153350B (enExample)
AU (1) AU2011290856B2 (enExample)
BR (1) BR112013003469A2 (enExample)
CA (1) CA2807491C (enExample)
CL (1) CL2013000483A1 (enExample)
ES (1) ES2626410T3 (enExample)
GB (1) GB201013808D0 (enExample)
IL (1) IL224463A (enExample)
MX (1) MX348733B (enExample)
MY (1) MY163136A (enExample)
NZ (1) NZ606466A (enExample)
PH (1) PH12013500270A1 (enExample)
RU (1) RU2594167C2 (enExample)
SG (1) SG187878A1 (enExample)
WO (1) WO2012022676A1 (enExample)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201103696D0 (en) * 2011-03-04 2011-04-20 Ge Healthcare Ltd Technetium labelled peptides
GB201121914D0 (en) 2011-12-20 2012-02-01 Ge Healthcare Ltd Method for patient selection
GB201209082D0 (en) * 2012-05-24 2012-07-04 Ge Healthcare Ltd Purification method
GB201221266D0 (en) * 2012-11-27 2013-01-09 Ge Healthcare Ltd Aldehyde compositions
GB201314936D0 (en) 2013-08-21 2013-10-02 Ge Healthcare Ltd Radiolabelling method
GB201322451D0 (en) * 2013-12-18 2014-02-05 Ge Healthcare Ltd Purification method and compositions
GB201322456D0 (en) * 2013-12-18 2014-02-05 Ge Healthcare Ltd Radiotracer compositions and methods
US20190151483A1 (en) * 2016-07-25 2019-05-23 The United States Of America, As Represented By The Secretary, Department Of Health And Human Serv Methods of making 18f-labeled precursors and peptides, labeled c-met binding peptides, and methods of use thereof
GB201804835D0 (en) * 2018-03-26 2018-05-09 Ge Healthcare As Formulation and method of preparation
MX2021015467A (es) 2019-06-14 2022-01-24 Edinburgh Molecular Imaging Ltd Compuestos y metodos de uso.
GB201915206D0 (en) * 2019-10-21 2019-12-04 Ge Healthcare Ltd Use of cyclodextrins as a radiostabilizer
SE2050387A1 (en) * 2020-04-06 2021-10-07 Pvac Medical Tech Ltd Labelled substance and methods of detection of inflammation and infection using said substance
TW202305012A (zh) * 2021-03-22 2023-02-01 日商肽夢想股份有限公司 c-Met 蛋白質結合肽複合物
GB202105950D0 (en) * 2021-04-26 2021-06-09 Ge Healthcare Ltd Analytical HPLC

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5961955A (en) * 1997-06-03 1999-10-05 Coulter Pharmaceutical, Inc. Radioprotectant for peptides labeled with radioisotope
WO2003057155A2 (en) 2001-12-27 2003-07-17 Van Andel Research Institute Monoclonal antibody imaging and therapy of tumors that express met and bind hepatocyte growth factor
ES2557286T3 (es) * 2003-03-03 2016-01-25 Dyax Corp. Usos de péptidos que se unen específicamente al receptor del HGF (cMet)
GB0305704D0 (en) * 2003-03-13 2003-04-16 Amersham Plc Radiofluorination methods
GB0420344D0 (en) * 2004-09-14 2004-10-13 Amersham Plc Diagnostic compounds
JP2009542689A (ja) * 2006-07-07 2009-12-03 ザ ボード オブ トラスティーズ オブ ザ リーランド スタンフォード ジュニア ユニバーシティ 選択的カスパーゼ阻害剤
GB0615211D0 (en) 2006-07-31 2006-09-06 Ge Healthcare Uk Ltd Asymmetric flouro-substituted polymethine dyes
BRPI0716554A2 (pt) 2006-09-08 2013-09-24 Bayer Schering Pharma Ag compostos de mÉtodos para agentes rotulados de 18f
EP2099499A2 (en) 2006-12-13 2009-09-16 GE Healthcare AS Synthesis of a radiofluorinated peptide using microwave activation technology
US8216548B2 (en) * 2006-12-28 2012-07-10 Ge Healthcare As Radiofluorination methods
BRPI0721424A2 (pt) * 2007-03-01 2014-03-25 Bayer Schering Pharma Aktiengesellschaft Métodos de radiofluoração
JP2010526859A (ja) * 2007-05-16 2010-08-05 ジーイー・ヘルスケア・アクスイェ・セルスカプ ペプチドイメージング剤
GB0718957D0 (en) * 2007-09-28 2007-11-07 Ge Healthcare Ltd Optical imaging agents
GB0718967D0 (en) 2007-09-28 2007-11-07 Ge Healthcare Ltd Peptide imaging agents
GB0716897D0 (en) * 2007-08-30 2007-10-10 Univ Muenchen Tech Cancer imaging and treatment
GB0803477D0 (en) 2008-02-26 2008-04-02 Ge Healthcare As Therapy selection method

Also Published As

Publication number Publication date
EP2605802B1 (en) 2017-04-26
GB201013808D0 (en) 2010-09-29
CA2807491A1 (en) 2012-02-23
SG187878A1 (en) 2013-03-28
BR112013003469A2 (pt) 2016-06-21
MY163136A (en) 2017-08-15
RU2594167C2 (ru) 2016-08-10
CA2807491C (en) 2019-06-04
EP2605802A1 (en) 2013-06-26
CN103153350A (zh) 2013-06-12
JP6014592B2 (ja) 2016-10-25
AU2011290856B2 (en) 2014-12-04
WO2012022676A1 (en) 2012-02-23
US9533059B2 (en) 2017-01-03
AU2011290856A1 (en) 2013-03-14
JP2013540702A (ja) 2013-11-07
KR101853993B1 (ko) 2018-05-02
RU2013105491A (ru) 2014-09-27
IL224463A (en) 2016-05-31
ES2626410T3 (es) 2017-07-25
US20130149241A1 (en) 2013-06-13
MX348733B (es) 2017-06-27
KR20130135242A (ko) 2013-12-10
PH12013500270A1 (en) 2013-04-01
CN103153350B (zh) 2016-06-29
MX2013001939A (es) 2013-03-18
NZ606466A (en) 2014-11-28

Similar Documents

Publication Publication Date Title
EP2680059A4 (en) PICTURE MECHANISM, ENDOSCOPE, AND METHOD FOR PRODUCING IMAGE RECEIVING MECHANISM
BR112015001098A2 (pt) composto, composição farmacêutica e método para o tratamento de uma condição de doença.
BRPI1016132A2 (pt) composição, formulação farmacêutica, método para fabricar uma formulação farmacêutica estável.
BR112014001274A2 (pt) composto de hormônio luteinizante, e, composição farmacêutica
IT1401367B1 (it) Metodo per combinare immagini riferentesi ad un contenuto tridimensionale.
BRPI1010261A2 (pt) agente e método de formação de imagem in vivo, composto precursos, métodos para a preparação de um composto precursor e do agente de formação de imagem in vivo, e para diagnostico de uma condição, kit, cassete,e , composição radiofarmaceutica.
EP2684561A4 (en) TABLETIC COMPOSITION FOR ORAL ADMINISTRATION AND METHOD FOR THE PRODUCTION THEREOF
EP2603834A4 (en) PROCESS FOR PRODUCING PICTURES
BR112013015796A2 (pt) composição de agente de formação de imagem, método de preparar uma composição de agente de formação de imagem, método de preparar um quelante 18f-nota, e, composição farmacêutica.
BR112014015042A2 (pt) composição farmacêutica, e, método para obter uma composição radiofarmacêutica
IL258357A (en) A semi-solid aqueous pharmaceutical preparation containing tapentadol
CL2013001085A1 (es) Un metodo para modular la concentracion de una o mas hormonas en un sujeto que comprende la administracion de una composicion que comprende un ligando del receptor quimiosensorial, donde la composicion esta adaptada para suministrar el ligando a una o mas regiones del intestino de tal sujeto.
EP2964722A4 (en) PROCESS FOR PROVIDING QUANTUM POINTS (QD)
BRPI0916936A8 (pt) composições faramacêuticas e métodos para produzir baixas concentrações de impureza das mesmas.
BRPI0909691A2 (pt) Composto, método para preparar um composto, e, composição farmacêutica
HUE047995T2 (hu) Dinamikus képkódoló készülék, dinamikus képkódoló eljárás, dinamikus képkódoló program
CL2014000328A1 (es) Metodo para preparar composicion que contiene un portador de oxigeno termoestable; composicion farmacéutica que comprende hemoglobina.
BR112012003280A2 (pt) composição farmacêutica para administração oral, método para tratar uma doença, uso do composto, e, composto.
BR112013007237A2 (pt) ''método para produzir um anticorpo anti-ig-1r''
BRPI1011531A2 (pt) composto, e , método para fluoração de 18f.
BR112013031575A2 (pt) composto peptídico ciclado de estrutura principal, composição farmacêutica, uso de composto, e, processo para a manufatura de um composto.
BR112013013285A2 (pt) agente de formação de imagem, precursor, métodos de preparação do agente de formação de imagem, e de formação de imagem, composição radiofarmacêutica, kit para a preparação da composição radiofarmacêutica, e, uso do agente de formação de imagem
BRPI0921464A2 (pt) processo para preparação de agente de contraste iodado
EP2533763C0 (de) Dermatologische, pharmazeutische zusammensetzung geeignet für oligonukleotide
EP2680871A4 (en) SYMBOLS HORMONE ANALOGUE, COMPOSITIONS THEREOF AND USES THEREOF